Aflac Incorporated (AFL)

Over the past six months, Aflac's stock has experienced some fluctuations. As of September 29, 2025, the stock price was $111.35, a slight decline from September 30, 2024. On October 1, 2025, the closing share price was $110.75, a decrease from the previous day, but up over the preceding 30 days. Year-to-date as of October 3, 2025, the shares were up approximately 8%. Aflac missed Wall Street's revenue expectations in Q2 CY2025, with sales decreasing and profit falling short of estimates. The successful launch of new cancer insurance in Japan and strong early sales are expected to drive future demand. Aflac is implementing digital initiatives to reduce costs and enhance customer engagement and is scheduled to release its third-quarter 2025 financial results on November 4, 2025.

The provided search results do not explicitly detail demand seasonality for Aflac's products and services. While the nature of supplemental health and life insurance might suggest a relatively stable demand throughout the year, specific seasonal trends were not mentioned.

Aflac, Inc. is a provider of financial protection through supplemental health and life insurance products, offering insurance solutions that disburse cash benefits for eligible claims. The company operates within the Financial Services sector, specifically in the Multi-line Insurance industry. Aflac's product portfolio includes cancer, medical, and life insurance, along with accident, disability, critical illness, hospital indemnity, dental, vision, nursing care, whole life, GIFT insurance products, WAYS, child endowment, and Tsumitasu insurance products.

Aflac's primary operations are in Japan and the United States, with its worldwide headquarters in Columbus, Georgia. In the U.S., Aflac has offices in Omaha, Nebraska; Columbia, South Carolina; Albany, New York; New York, New York; Atlanta, Georgia; and Washington, D.C. Aflac provides financial protection to over 50 million people globally.

Aflac has maintained a strong brand reputation, receiving accolades such as being recognized by Fortune Magazine as one of the World's Most Admired Companies for the 23rd time and ranking No. 1 in the Insurance: Life and Health category for long-term investment for the second consecutive year. The company has been named one of the World's Most Ethical Companies by Ethisphere for multiple consecutive years and has been included in the Dow Jones Sustainability North America Index for 11 years. The Aflac Duck advertising campaign has significantly boosted brand recognition and U.S. sales.

Institutional investors hold a significant majority of Aflac's shares, owning approximately 66% to 69% of the company. Japan Post Holdings Co., Ltd. is the largest shareholder, followed by Vanguard Group Inc. and BlackRock, Inc. Individual investors, including retail investors and insiders, collectively own about 34% of the company. CEO Daniel Amos holds 0.6% of the company's shares, and total insider ownership is approximately 0.65%.